Search Results - "Gandjini, H"

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study by Florescu, I., Beuran, M., Dimov, R., Razbadauskas, A., Bochan, M., Fichev, G., Dukart, G., Babinchak, T., Cooper, C. A., Ellis-Grosse, E. J., Dartois, N., Gandjini, H.

“…Introduction Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are causing serious nosocomial infections…”
Get full text

Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial by Gerbes, Alexander L., Gülberg, Veit, Ginès, Pere, Decaux, Guy, Gross, Peter, Gandjini, Hassan, Djian, Jacques

“…Background & Aims: Dilutional hyponatremia is a frequent complication of cirrhosis partly because of nonosmotic vasopressin release. No effective therapy…”
Get full text

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia: European Experience by Dartois, N., Castaing, N., Gandjini, H., Cooper, A.

“…Tigecycline (TGC), a first-in-class glycylcycline that has been approved for treating complicated skin and skin structure infections and complicated…”
Get full text

P848 Efficacy of tigecycline (TGC) compared with levofloxacin (LEV) for treating Streptococcus pneumoniae bacteraemia in patients (pts) hospitalised with community-acquired pneumonia (CAP) by Dartois, N, Dukart, G, Cooper, C.A, Castaing, N, Gandjini, H

Get full text

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae by Vasilev, Krasimir, Reshedko, Galina, Orasan, Remus, Sanchez, Miguel, Teras, Juri, Babinchak, Tim, Dukart, Gary, Cooper, Angel, Dartois, Nathalie, Gandjini, Hassan, Orrico, Russ, Ellis-Grosse, Evelyn

“…Objectives To evaluate the efficacy and safety of tigecycline in patients with selected serious infections caused by resistant Gram-negative bacteria, or…”
Get full text

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia by Tanaseanu, Cristina, Bergallo, Carlos, Teglia, Osvaldo, Jasovich, Abel, Oliva, Maria Eugenia, Dukart, Gary, Dartois, Nathalie, Cooper, C. Angel, Gandjini, Hassan, Mallick, Rajiv

“…Abstract Tigecycline (TGC), a glycylcycline, has expanded activity against Gram-positive and Gram-negative, anaerobic, and atypical bacteria. Two phase 3…”
Get full text

Effect of acute glycerol administration with or without a mixed meal in humans by Nicolaïew, N, Cavallero, E, Gandjini, H, Dolé, E, Koziet, J, Gambert, P, François, A, Jacotot, B

“…We explored the effects of oral glycerol administration (20 g) alone or in combination with a mixed meal on postprandial lipids, free fatty acids, high-density…”
Get more information

Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects by LAGROST, L, GANDJINI, H, ATHIAS, A, GUYARD-DANGREMONT, V, LALLEMANT, C, GAMBERT, P

“…The relations of cholesteryl ester transfer protein (CETP) activity to the distribution of low density lipoproteins (LDLs) and high density lipoproteins (HDLs)…”
Get full text

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia : European Experience: Tigecycline: European Experience by DARTOIS, N, CASTAING, N, GANDJINI, H, COOPER, A

Get full text

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci : a Phase 3, multicentre, double-blind, randomized study: Tigecycline, a therapeutic option from a new antimicrobial class (the glycylcyclines) in an era of increasing resistance by FLORESCU, I, BEURAN, M, DARTOIS, N, GANDJINI, H, DIMOV, R, RAZBADAUSKAS, A, BOCHAN, M, FICHEV, G, DUKART, G, BABINCHAK, T, COOPER, C. A, ELLIS-GROSSE, E. J

Get full text

Effect of LDL oxidation on the immunoreactivity of human apolipoprotein B by Gandjini, H, Gambert, P

Get more information

Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma by Lagrost, Laurent, Florentin, Emmanuel, Guyard-Dangremont, Valerie, Athias, Anne, Gandjini, Hassan, Lallemant, Christian, Gambert, Philippe

“…The relations between the level of plasma nonesterified fatty acid (NEFA) and both the mass concentration and activity of the cholesteryl ester transfer…”
Get full text

Resistance to LDL oxidative modifications of an N-terminal apolipoprotein B epitope by Gandjini, H, Gambert, P, Athias, A, Lallemant, C

“…The immunoreactivity of human apolipoprotein B (apo B) towards 5 monoclonal antibodies was studied by enzyme immunoassay in native and in vitro oxidized low…”
Get more information

Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns by Gandjini, H, Gambert, P, Athias, A, Mousson, C, Rifle, G, Lallemant, C

“…The changes in low density lipoprotein (LDL) composition and immunoreactivity occurring after LDL-apheresis on dextran sulfate-cellulose columns (DSC) were…”
Get more information